Found: 19
Select item for more details and to access through your institution.
Methods for assessing the preventability of adverse drug events: a systematic review.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Modelling drug-related morbidity in Sweden using an expert panel of pharmacists'.
- Published in:
- International Journal of Clinical Pharmacy, 2012, v. 34, n. 4, p. 538, doi. 10.1007/s11096-012-9641-3
- By:
- Publication type:
- Article
Adherence to Antihypertensive Therapy and Elevated Blood Pressure: Should We Consider the Use of Multiple Medications?
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0137451
- By:
- Publication type:
- Article
Economic Impact of Adverse Drug Events – A Retrospective Population-Based Cohort Study of 4970 Adults.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0092061
- By:
- Publication type:
- Article
Prevalence and Perceived Preventability of Self-Reported Adverse Drug Events – A Population-Based Survey of 7099 Adults.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0073166
- By:
- Publication type:
- Article
Percentage of Patients with Preventable Adverse Drug Reactions and Preventability of Adverse Drug Reactions - A Meta-Analysis.
- Published in:
- PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0033236
- By:
- Publication type:
- Article
Prevalence, nature and potential preventability of adverse drug events - a population-based medical record study of 4970 adults.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 78, n. 1, p. 170, doi. 10.1111/bcp.12314
- By:
- Publication type:
- Article
An observational post‐authorization safety study (PASS) of naloxegol drug utilization in four European countries.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 1, p. 1, doi. 10.1002/pds.5710
- By:
- Publication type:
- Article
Observational evidence from patients diagnosed with chronic lymphocytic leukaemia (CLL) in Finland between 2005‐2015 show improved survival over time.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 3, p. 190, doi. 10.1111/ejh.13273
- By:
- Publication type:
- Article
Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study.
- Published in:
- European Journal of Clinical Pharmacology, 2015, v. 71, n. 12, p. 1525, doi. 10.1007/s00228-015-1950-8
- By:
- Publication type:
- Article
The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses' reporting.
- Published in:
- European Journal of Clinical Pharmacology, 2015, v. 71, n. 5, p. 631, doi. 10.1007/s00228-015-1839-6
- By:
- Publication type:
- Article
Modelling drug-related morbidity in Sweden using an expert panel of physicians.
- Published in:
- European Journal of Clinical Pharmacology, 2012, v. 68, n. 9, p. 1309, doi. 10.1007/s00228-012-1244-3
- By:
- Publication type:
- Article
Pharmacoepidemiology at Nordic School of Public Health NHV: Examples from 1999 to 2014.
- Published in:
- Scandinavian Journal of Public Health, 2015, v. 43, n. S16, p. 73, doi. 10.1177/1403494814568600
- By:
- Publication type:
- Article
(DXT50) Prevalence of Serious Adverse Pregnancy Outcomes After Exposure to Interferon Beta Before or During Pregnancy: Stratification by Characteristics of Pregnant Women with Multiple Sclerosis in a Register-Based Cohort Study in Finland and Sweden.
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 33
- By:
- Publication type:
- Article
Refill adherence and self-reported adverse drug reactions and sub-therapeutic effects: a population-based study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2013, v. 22, n. 12, p. 1317, doi. 10.1002/pds.3528
- By:
- Publication type:
- Article
Preventable drug related mortality in a Swedish population.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2010, v. 19, n. 2, p. 211, doi. 10.1002/pds.1890
- By:
- Publication type:
- Article
Pregnancy outcomes after exposure to interferon beta: a register-based cohort study among women with MS in Finland and Sweden.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, p. 1, doi. 10.1177/1756286420951072
- By:
- Publication type:
- Article
Pregnancy outcomes after exposure to interferon beta: a register-based cohort study among women with MS in Finland and Sweden.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420951072
- By:
- Publication type:
- Article
Prenatal exposure to pregabalin, birth outcomes and neurodevelopment – a population-based cohort study in four Nordic countries.
- Published in:
- Drug Safety, 2023, v. 46, n. 7, p. 661, doi. 10.1007/s40264-023-01307-2
- By:
- Publication type:
- Article